The engineered LHRH-BinBC toxin has selective cytotoxicity against LHRH-positive cells in vitro (MCF-7 cells) and may induce cell death via apoptosis, making it a potential alternative treatment for breast cancer. This evidence concerns the gene GNRH1 and breast carcinoma.